MD Revolution has launched RevConnect Workflow, an embedded low-code/no-code integration platform that enables healthcare ...

Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last close.

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

The Taliban has become a direct threat to Pakistan, using American-supplied weapons to launch attacks within its borders and ...

The 10th magnificent stock that can make you richer in 2025 is none other than payment-processing goliath Visa (NYSE: V).

Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.22%. Elsewhere, the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Finbold asked ChatGPT which undervalued stocks of 2024 are worth tracking - and possibly investing in - in 2025.

Jefferies analyst Maury Raycroft lowered the firm’s price target on Sangamo (SGMO) to $3 from $7 and keeps a Buy rating on the shares after the ...

After years of almost constant struggle, one crisis after another, the financial markets finally got some respite in 2024.

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...